Cargando…

Validation of T-MoCA in the Screening of Mild Cognitive Impairment in Chinese Patients With Atrial Fibrillation

BACKGROUND: Atrial fibrillation (AF) is associated with a high risk of mild cognitive impairment (MCI) and dementia. However, feasible and simple instruments that facilitate the regular assessment of cognitive status in patients with AF remain underdeveloped. METHODS: Cognitive function was first ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Yiwei, Zhao, Manlin, Jiang, Chao, Du, Xin, Wang, Zhiyan, Zhang, Jingrui, Bai, Yu, Xu, Baolei, Zhang, Weiwei, Tang, Ribo, Sang, Caihua, Long, Deyong, Dong, Jianzeng, Ma, Changsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257241/
https://www.ncbi.nlm.nih.gov/pubmed/35811734
http://dx.doi.org/10.3389/fcvm.2022.896846
_version_ 1784741301178073088
author Lai, Yiwei
Zhao, Manlin
Jiang, Chao
Du, Xin
Wang, Zhiyan
Zhang, Jingrui
Bai, Yu
Xu, Baolei
Zhang, Weiwei
Tang, Ribo
Sang, Caihua
Long, Deyong
Dong, Jianzeng
Ma, Changsheng
author_facet Lai, Yiwei
Zhao, Manlin
Jiang, Chao
Du, Xin
Wang, Zhiyan
Zhang, Jingrui
Bai, Yu
Xu, Baolei
Zhang, Weiwei
Tang, Ribo
Sang, Caihua
Long, Deyong
Dong, Jianzeng
Ma, Changsheng
author_sort Lai, Yiwei
collection PubMed
description BACKGROUND: Atrial fibrillation (AF) is associated with a high risk of mild cognitive impairment (MCI) and dementia. However, feasible and simple instruments that facilitate the regular assessment of cognitive status in patients with AF remain underdeveloped. METHODS: Cognitive function was first evaluated using telephone Montreal cognitive assessment (T-MoCA), and then patients were invited for an in-person interview for cognitive assessment using both Clinical Dementia Rating (CDR) and mini-mental status evaluation (MMSE). Using CDR = 0.5 as a reference standard, the ability of T-MoCA and MMSE to discriminate cognitive dysfunction, stratified by education level, was tested by receiver–operating curve (ROC) analysis. The net reclassification index was calculated for comparison between the performance of T-MoCA and MMSE. RESULTS: One hundred and one patients completed both telephone and in-person interview. Thirty-five MCI patients were identified as MCI using the criteria of CDR = 0.5. The areas under the ROC curve of T-MoCA were 0.80 (0.71–0.89), 0.83 (0.71–0.95), and 0.85 (0.64–0.92) for all patients, patients with high educational level, and patients with low education level, respectively. The optimal threshold was achieved at 16/17 with a sensitivity of 85.7% and a specificity of 69.7% in overall patients, 15/16 with a sensitivity of 88.2% and a specificity of 64.5% in the low educational level patients, and 16/17 with a sensitivity of 77.8% and a specificity of 87.9% in the high educational level patients. Compared to the criterion MMSE ≤ 27 and MMSE norms for the elderly Chinese community, the stratified T-MoCA threshold improves correct classification by 23.7% (p = 0.033) and 30.3% (p = 0.020), respectively. CONCLUSION: T-MoCA is a feasible and effective instrument for MCI screening in patients with AF.
format Online
Article
Text
id pubmed-9257241
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92572412022-07-07 Validation of T-MoCA in the Screening of Mild Cognitive Impairment in Chinese Patients With Atrial Fibrillation Lai, Yiwei Zhao, Manlin Jiang, Chao Du, Xin Wang, Zhiyan Zhang, Jingrui Bai, Yu Xu, Baolei Zhang, Weiwei Tang, Ribo Sang, Caihua Long, Deyong Dong, Jianzeng Ma, Changsheng Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Atrial fibrillation (AF) is associated with a high risk of mild cognitive impairment (MCI) and dementia. However, feasible and simple instruments that facilitate the regular assessment of cognitive status in patients with AF remain underdeveloped. METHODS: Cognitive function was first evaluated using telephone Montreal cognitive assessment (T-MoCA), and then patients were invited for an in-person interview for cognitive assessment using both Clinical Dementia Rating (CDR) and mini-mental status evaluation (MMSE). Using CDR = 0.5 as a reference standard, the ability of T-MoCA and MMSE to discriminate cognitive dysfunction, stratified by education level, was tested by receiver–operating curve (ROC) analysis. The net reclassification index was calculated for comparison between the performance of T-MoCA and MMSE. RESULTS: One hundred and one patients completed both telephone and in-person interview. Thirty-five MCI patients were identified as MCI using the criteria of CDR = 0.5. The areas under the ROC curve of T-MoCA were 0.80 (0.71–0.89), 0.83 (0.71–0.95), and 0.85 (0.64–0.92) for all patients, patients with high educational level, and patients with low education level, respectively. The optimal threshold was achieved at 16/17 with a sensitivity of 85.7% and a specificity of 69.7% in overall patients, 15/16 with a sensitivity of 88.2% and a specificity of 64.5% in the low educational level patients, and 16/17 with a sensitivity of 77.8% and a specificity of 87.9% in the high educational level patients. Compared to the criterion MMSE ≤ 27 and MMSE norms for the elderly Chinese community, the stratified T-MoCA threshold improves correct classification by 23.7% (p = 0.033) and 30.3% (p = 0.020), respectively. CONCLUSION: T-MoCA is a feasible and effective instrument for MCI screening in patients with AF. Frontiers Media S.A. 2022-06-22 /pmc/articles/PMC9257241/ /pubmed/35811734 http://dx.doi.org/10.3389/fcvm.2022.896846 Text en Copyright © 2022 Lai, Zhao, Jiang, Du, Wang, Zhang, Bai, Xu, Zhang, Tang, Sang, Long, Dong and Ma. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Lai, Yiwei
Zhao, Manlin
Jiang, Chao
Du, Xin
Wang, Zhiyan
Zhang, Jingrui
Bai, Yu
Xu, Baolei
Zhang, Weiwei
Tang, Ribo
Sang, Caihua
Long, Deyong
Dong, Jianzeng
Ma, Changsheng
Validation of T-MoCA in the Screening of Mild Cognitive Impairment in Chinese Patients With Atrial Fibrillation
title Validation of T-MoCA in the Screening of Mild Cognitive Impairment in Chinese Patients With Atrial Fibrillation
title_full Validation of T-MoCA in the Screening of Mild Cognitive Impairment in Chinese Patients With Atrial Fibrillation
title_fullStr Validation of T-MoCA in the Screening of Mild Cognitive Impairment in Chinese Patients With Atrial Fibrillation
title_full_unstemmed Validation of T-MoCA in the Screening of Mild Cognitive Impairment in Chinese Patients With Atrial Fibrillation
title_short Validation of T-MoCA in the Screening of Mild Cognitive Impairment in Chinese Patients With Atrial Fibrillation
title_sort validation of t-moca in the screening of mild cognitive impairment in chinese patients with atrial fibrillation
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257241/
https://www.ncbi.nlm.nih.gov/pubmed/35811734
http://dx.doi.org/10.3389/fcvm.2022.896846
work_keys_str_mv AT laiyiwei validationoftmocainthescreeningofmildcognitiveimpairmentinchinesepatientswithatrialfibrillation
AT zhaomanlin validationoftmocainthescreeningofmildcognitiveimpairmentinchinesepatientswithatrialfibrillation
AT jiangchao validationoftmocainthescreeningofmildcognitiveimpairmentinchinesepatientswithatrialfibrillation
AT duxin validationoftmocainthescreeningofmildcognitiveimpairmentinchinesepatientswithatrialfibrillation
AT wangzhiyan validationoftmocainthescreeningofmildcognitiveimpairmentinchinesepatientswithatrialfibrillation
AT zhangjingrui validationoftmocainthescreeningofmildcognitiveimpairmentinchinesepatientswithatrialfibrillation
AT baiyu validationoftmocainthescreeningofmildcognitiveimpairmentinchinesepatientswithatrialfibrillation
AT xubaolei validationoftmocainthescreeningofmildcognitiveimpairmentinchinesepatientswithatrialfibrillation
AT zhangweiwei validationoftmocainthescreeningofmildcognitiveimpairmentinchinesepatientswithatrialfibrillation
AT tangribo validationoftmocainthescreeningofmildcognitiveimpairmentinchinesepatientswithatrialfibrillation
AT sangcaihua validationoftmocainthescreeningofmildcognitiveimpairmentinchinesepatientswithatrialfibrillation
AT longdeyong validationoftmocainthescreeningofmildcognitiveimpairmentinchinesepatientswithatrialfibrillation
AT dongjianzeng validationoftmocainthescreeningofmildcognitiveimpairmentinchinesepatientswithatrialfibrillation
AT machangsheng validationoftmocainthescreeningofmildcognitiveimpairmentinchinesepatientswithatrialfibrillation